Glycosaminoglycans: A new paradigm in the prevention of proteinuria and progression of glomerular disease

被引：25

作者：

Gambaro, G ^{[1
]}

Baggio, B ^{[1
]}

机构：

[1] UNIV HOSP PADUA,INST INTERNAL MED,DIV NEPHROL,PADUA,ITALY

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 1996年 / 11卷 / 05期

关键词：

D O I：

10.1093/oxfordjournals.ndt.a027392

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：762 / 764

页数：3

共 17 条

[1]

BORDER WA, 1984, AM J KIDNEY DIS, V3, P308, DOI 10.1016/S0272-6386(84)80051-7

[2]

CEOL A, 1995, DIABETOLOGIA, V38, pA62

[3]

CEOL M, IN PRESS LAB INVEST

[4]

COFFEY AK, 1985, AM J PATHOL, V120, P248

[5]

DIAMOND JR, 1986, RENAL PHYSIOL BIOCH, V9, P366

[6] HEPARIN SUPPRESSES MESANGIAL CELL-PROLIFERATION AND MATRIX EXPANSION IN EXPERIMENTAL MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS [J].

FLOEGE, J ;

ENG, E ;

YOUNG, BA ;

COUSER, WG ;

JOHNSON, RJ .

KIDNEY INTERNATIONAL, 1993, 43 (02) :369-380

[7] GLYCOSAMINOGLYCANS PREVENT MORPHOLOGICAL RENAL ALTERATIONS AND ALBUMINURIA IN DIABETIC RATS [J].

GAMBARO, G ;

CAVAZZANA, AO ;

LUZI, P ;

PICCOLI, A ;

BORSATTI, A ;

CREPALDI, G ;

MARCHI, E ;

VENTURINI, AP ;

BAGGIO, B .

KIDNEY INTERNATIONAL, 1992, 42 (02) :285-291

[8] TREATMENT WITH A GLYCOSAMINOGLYCAN FORMULATION AMELIORATES EXPERIMENTAL DIABETIC NEPHROPATHY [J].

GAMBARO, G ;

VENTURINI, AP ;

NOONAN, DM ;

FRIES, W ;

RE, G ;

GARBISA, S ;

MILANESI, C ;

PESARINI, A ;

BORSATTI, A ;

MARCHI, E ;

BAGGIO, B .

KIDNEY INTERNATIONAL, 1994, 46 (03) :797-806

[9] EFFECT OF HEPARIN ON THE GLOMERULAR STRUCTURE AND FUNCTION OF REMNANT NEPHRONS [J].

ICHIKAWA, I ;

YOSHIDA, Y ;

FOGO, A ;

PURKERSON, ML ;

KLAHR, S .

KIDNEY INTERNATIONAL, 1988, 34 (05) :638-644

[10]

MARSHALL SM, 1995, EFFECTS HEPARIN RENA, V38, pA207

← 1 2 →